Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer

NCT05737303 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

538

Enrollment

OTHER

Sponsor class

Conditions

Epithelial Ovarian Carcinoma Stage III
Epithelial Ovarian Carcinoma Stage IV
Fallopian Tube Carcinoma Stage III
Fallopian Tube Carcinoma Stage IV
Primary Peritoneal Carcinoma Stage III
Primary Peritoneal Carcinoma Stage IV

Interventions

DRUG: nab-paclitaxel combined with carboplatin

Sponsor

Women's Hospital School Of Medicine Zhejiang University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]